The mAKAP complex plays a critical role in adrenergic-mediated cardiac myocyte hypertrophy by integrating cAMP and Ca2+ signals, suggesting a potential therapeutic target for heart failure.
No takes yet. Share an insight, caveat, or question.
Targeting mAKAP may limit myocyte hypertrophy in models; leaves open therapeutic translation to human heart failure.
Paré et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: